Related Experiment Video
Updated: May 16, 2026

06:53
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
Published on: June 8, 2019
NIPT detects occult maternal malignancies via cfDNA aberration profiling: a case report
Liqiong Wu1, Xiaohua Wang1, Jin An1
1Department of Genetics, Inner Mongolia Maternity and Child Health Care Hospital, Hohhot, China.
Frontiers in Medicine
|May 15, 2026
Summary
Non-Invasive Prenatal Testing (NIPT) can incidentally detect maternal cancers by analyzing cell-free DNA (cfDNA). Further research is needed to improve accuracy for early cancer detection in women.
Area of Science:
- Genomics
- Oncology
- Maternal-Fetal Medicine
Background:
- Non-Invasive Prenatal Testing (NIPT) screens for fetal aneuploidies.
- Abnormal cell-free DNA (cfDNA) patterns in NIPT can indicate occult maternal malignancies.
- Incidental cancer detection via NIPT has been reported for breast, ovarian cancers, and lymphoma.
Keywords:
Non-Invasive Prenatal Testing (NIPT)cell-free DNA (cfDNA)copy number variation (CNV)hepatocellular carcinomamaternal malignancy
